DIBUTYL SEBACATE
CASRN#
109-43-3
INCI Name
DIBUTYL SEBACATE
Alternate Names
Dibutyl decanedioate; Butyl sebacate; Di-n-butyl sebacate, Decanedioic acid dibutyl ester, Bis(n-butyl) sebacate, Di-n-butylsebacate, Sebacic acid dibutyl ester, Bis(n-butyl)sebacate; Decanedioic acid, 1,10-dibutyl ester
Common Trade Names
Polycizer DBS, Kodaflex DBS, Staflex DBS, Monoplex DBS
Molecular Weight
314 g/mol
Functional Uses
Solvent; plasticizer
Common Impurities
-
Is this a VOC?
No
Is this an exempt VOC?
No
Vapor Pressure
0.00000469 mm Hg
Octanol-water partition coefficient (log Kow)
6.3
Solubility at 2E+1 C
4E+1 mg/l
Boiling Point
344.5 °C
Particle size range as aerodynamic diameter
- - - μm
Hazard Summary
C2C Chemical Rating
grey/c
GHS Health
H320
GHS Enviro
H411
Assessed by
U.S. EPA Low Priority Chemical report.
Assessment Date
Jul 10, 2020
Assessment Expires
Jul 9, 2025
Verification Status
verified
Executive Summary
Dibutyl sebacate is an ester of sebacic acid -a saturated, straight-10-carbon-chain, naturally occurring dicarboxylic acid that is derived from castor oil. An ester is an organic chemical compound derived from an acid in which a hydroxyl (-OH) group is replaced by an alkoxy (-OR) group through the process of esterification. Shorter chain aliphatic diesters, such as dibutyl sebacate, function as plasticizers to give improved flexibility and resistance to cracking at low temperatures. A plasticizer is a substance that is added to a material to alter its physical properties, mainly to increase flexibility or decrease viscosity. These aliphatic diesters are also versatile solvents in that they are able to dissolve a wide range of organic compounds. NOTE: The data provided in this assessment came primarily from the US EPA final designation report, Supporting Information for Low-Priority Substance Decanedioic acid, 1,10-dibutyl ester (Dibutyl Sebacate) (https://www.regulations.gov/document?D=EPA-HQ-OPPT-2019-0113-0010). According to US EPA, “low-priority substance designations give the public notice of chemical substances for which the hazard and/or exposure potential is anticipated to be low or nonexistent and provides some insight into which chemical substances are likely not to need additional evaluation and risk management under TSCA.”
Hazard Tables

How to read the GHS Hazard Summary Table

 
Carcinogenicity
Mutagenicity
Reproductive Toxicity
Developmental Toxicity
Acute Toxicity
STOT-Single
STOT-Repeated
STOT- Neurotoxicity-Single
STOT- Neurotoxicity-Repeated
Skin Sensitizer
Respiratory Sensitizer
Skin Corrosion/Irritation
Serious Eye Damage/Eye Irritation
Acute Aquatic Toxicity
Chronic Aquatic Toxicity
Ozone Depletion
Oral
Dermal
Inhalation
NC
Rationale
These results provide sufficient information to indicate low concern for carcinogenicity by dibutyl sebacate.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
Chromosomal aberration assay on dibutyl sebacate and bacterial mutation studies on analogs provide sufficient information to indicate dibutyl sebacate has low concern for inducing genotoxicity. Lower confidence due to use of analogs.
NC
Rationale
Lower confidence due to analog study. One generation reproductive study provides sufficient information to indicate low concern for reproductive toxicity by exceeding the low-concern benchmarks of 250 mg/kg-day for oral exposures.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
Lower confidence due to analog study. One generation reproductive study provides sufficient information to indicate low concern for developmental toxicity by exceeding the low-concern benchmarks of 250 mg/kg-day for oral exposures.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
Studies provide sufficient information to indicate low concern for mammalian toxicity from acute oral exposure to dibutyl sebacate.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
CNP
Rationale
No data available.
NC
Rationale
Studies provide sufficient information to indicate low concern for mammalian toxicity from repeated oral exposure to dibutyl sebacate.
CNP
Rationale
Data not available.
CNP
Rationale
Data not available.
NC
Rationale
While no traditional neurotoxicity studies were available for dibutyl sebacate or closely-related analogs, the available data from repeated dose exposure and NAMs provide sufficient evidence to indicate a low concern for neurotoxicity.
NC
Rationale
While no traditional neurotoxicity studies were available for dibutyl sebacate or closely-related analogs, the available data from repeated dose exposure and NAMs provide sufficient evidence to indicate a low concern for neurotoxicity.
NC
Rationale
While no traditional neurotoxicity studies were available for dibutyl sebacate or closely-related analogs, the available data from repeated dose exposure and NAMs provide sufficient evidence to indicate a low concern for neurotoxicity.
NC
Rationale
While no traditional neurotoxicity studies were available for dibutyl sebacate or closely-related analogs, the available data from repeated dose exposure and NAMs provide sufficient evidence to indicate a low concern for neurotoxicity.
NC
Rationale
While no traditional neurotoxicity studies were available for dibutyl sebacate or closely-related analogs, the available data from repeated dose exposure and NAMs provide sufficient evidence to indicate a low concern for neurotoxicity.
NC
Rationale
While no traditional neurotoxicity studies were available for dibutyl sebacate or closely-related analogs, the available data from repeated dose exposure and NAMs provide sufficient evidence to indicate a low concern for neurotoxicity.
NC
Rationale
No structural alerts identified for skin sensitization. Lower confidence because a lack of structural alerts is insufficient for establishing a GHS classification.
NC
Rationale
No structural alerts identified for respiratory sensitization. Lower confidence because a lack of structural alerts is insufficient for establishing a GHS classification.
NC
Rationale
Analog studies provide sufficient information to indicate that dibutyl sebacate has low concern for skin irritation.
Cat 2B
Rationale
A study in rabbits indicate moderate concern for eye irritation from dibutyl sebacate.
NC
Rationale
Results provide suffiient information to indicate dibutyl sebacate is a low concern for acute aquatic exposures. Lower confidence due to modelling.
Cat 2
Rationale
Modelling indicates high concern for chronic aquatic toxicity, however studies that demonstrate ready biodegradation reduce that concern. Collectively, these data provide sufficient evidence dibutyl sebecate is a low concern for chronic aquatic toxicity to vertebrates. Lower confidence based on modelling.
NC
Rationale
Chemical is not on Montreal Protocol or IPCC list.
Other
  • Explosives: Not classified
  • Flammable Gases: Not classified
  • Aerosols: Not classified
  • Oxidizing Gases: Not classified
  • Flammable Liquids: Not classified
  • Flammable Solids: Not classified
  • Self-reactive substances and mixtures: Not classified
  • Pyrophoric Liquids: Not classified
  • Pyrophoric Solids: Not classified
  • Self-heating Substances and Mixtures: Not classified
  • Substances and Mixtures which in contact with water, emit flammable gases: Not classified
  • Oxidizing Liquids: Not classified
  • Oxidizing Solids: Not classified
  • Organic Peroxides: Not classified
  • Corrosive to Metals: Not classified
  • Desensitized Explosives: Not classified

How to read the C2CC Hazard Summary Table

Human Health
Environmental
Other
 
Carcinogenicity
Mutagenicity
Reproductive & Developmental Toxicity
Endocrine Activity / Disruption
Oral Toxicity
Dermal Toxicity
Inhalation Toxicity
Neurotoxicity
Skin, Eye, and Respiratory Corrosion/Irritation
Sensitization of Skin and Airways
Fish Toxicity
Daphnia Toxicity
Algae Toxicity
Terrestrial Toxicity
Persistence
Bioaccumulation
Climatic Relevance
Other (Human Health)
Organohalogens
Toxic Metals
Other (Environmental Health)
Oral
Dermal
Inhalation
G
-
-
G
G
-
-
-
Rationale
Data not available.
G
-
-
G
G
G
Y
G
R
G
R
G
G
Rationale
Studies on analogs provide sufficient evidence of low concern for persistence. Lower confidence due to analog data.
G
Rationale
Based on the estimated bioaccumulation factor (BAF) value of 29 using the Estimation Programs Interface (EPI) Suite models, EPA has sufficient information that dibutyl sebacate is expected to have low potential for bioaccumulation in the environment based on the low-concern benchmark of less than 1000.
G
G
Rationale
No additional data available.
G
G
G
Rationale
No additional data available.